A series of experiments were conducted to test effects and relevant cellular/molecular mechanisms of GLP-1 (9-36) treatment on cognitive impairments and synaptic plasticity deficiency in Ts65Dn DS model mice. The gene discussed is GCG; the disease is Cognitive impairment.